Literature DB >> 14597423

The Us3 protein kinase of herpes simplex virus 1 blocks apoptosis and induces phosporylation of the Bcl-2 family member Bad.

Anna Cartier1, Tomoaki Komai, Maria G Masucci.   

Abstract

Viruses have evolved different strategies to interfere with apoptotic pathways in order to halt cellular responses to infection. The herpes simplex virus 1 (HSV-1) Us3 open-reading frame encodes a serine/threonine protein kinase that participates in the inhibition of apoptosis induced by virus infection and other stress agents. Previous studies have shown that Us3 counteracts the virus-induced activation of caspase-3 by acting at a premitochondrial stage. Using stable transfectants that express Us3 under the control of constitutive or inducible promoters we demonstrate that apoptosis induced by treatment with anti-Fas antibody and sorbitol is blocked when Us3 is expressed at levels comparable to those achieved during virus infection. Expression of Us3 correlated with phosphorylation of Bad, a BH3-only proapoptotic Bcl-2 family member that is also a target for growth factor-induced cellular kinases. Bad was phosphorylated by Us3 in in vitro kination assays. These results point to a strategy for viral inhibition of apoptosis based on functional inactivation of a critical component of the cellular death machinery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597423     DOI: 10.1016/s0014-4827(03)00375-6

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  29 in total

1.  Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis.

Authors:  Luca Benetti; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

Review 2.  Viral serine/threonine protein kinases.

Authors:  Thary Jacob; Céline Van den Broeke; Herman W Favoreel
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

3.  Identification of proteins phosphorylated directly by the Us3 protein kinase encoded by herpes simplex virus 1.

Authors:  Akihisa Kato; Mayuko Yamamoto; Takashi Ohno; Hiroshi Kodaira; Yukihiro Nishiyama; Yasushi Kawaguchi
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Role of group A p21-activated kinases in the anti-apoptotic activity of the pseudorabies virus US3 protein kinase.

Authors:  C Van den Broeke; M Radu; H J Nauwynck; J Chernoff; H W Favoreel
Journal:  Virus Res       Date:  2010-11-18       Impact factor: 3.303

5.  Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31.

Authors:  Akihisa Kato; Mayuko Yamamoto; Takashi Ohno; Michiko Tanaka; Tetsutaro Sata; Yukihiro Nishiyama; Yasushi Kawaguchi
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Two viral kinases are required for sustained long distance axon transport of a neuroinvasive herpesvirus.

Authors:  Kelly E Coller; Gregory A Smith
Journal:  Traffic       Date:  2008-06-28       Impact factor: 6.215

Review 7.  Varicella-zoster virus open reading frame 66 protein kinase and its relationship to alphaherpesvirus US3 kinases.

Authors:  Angela Erazo; Paul R Kinchington
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

8.  Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production.

Authors:  Shuai Wang; Kezhen Wang; Rongtuan Lin; Chunfu Zheng
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

9.  Protein kinase B/Akt is present in activated form throughout the entire replicative cycle of deltaU(S)3 mutant virus but only at early times after infection with wild-type herpes simplex virus 1.

Authors:  Luca Benetti; Bernard Roizman
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells.

Authors:  Piritta Peri; Riikka K Mattila; Helena Kantola; Eeva Broberg; Heidi S Karttunen; Matti Waris; Tytti Vuorinen; Veijo Hukkanen
Journal:  Virol J       Date:  2008-11-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.